These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 17884192

  • 1. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
    Udawela M, Christopoulos G, Morfis M, Tilakaratne N, Christopoulos A, Sexton PM.
    Regul Pept; 2008 Jan 10; 145(1-3):65-71. PubMed ID: 17884192
    [Abstract] [Full Text] [Related]

  • 2. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.
    Zumpe ET, Tilakaratne N, Fraser NJ, Christopoulos G, Foord SM, Sexton PM.
    Biochem Biophys Res Commun; 2000 Jan 07; 267(1):368-72. PubMed ID: 10623626
    [Abstract] [Full Text] [Related]

  • 3. A critical role for the short intracellular C terminus in receptor activity-modifying protein function.
    Udawela M, Christopoulos G, Morfis M, Christopoulos A, Ye S, Tilakaratne N, Sexton PM.
    Mol Pharmacol; 2006 Nov 07; 70(5):1750-60. PubMed ID: 16912219
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T, Christopoulos G, Bailey RJ, Christopoulos A, Sexton PM, Hay DL.
    Mol Pharmacol; 2008 Oct 07; 74(4):1059-71. PubMed ID: 18593822
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.
    Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ, Main MJ, Foord SM, Sexton PM.
    Mol Pharmacol; 1999 Jul 07; 56(1):235-42. PubMed ID: 10385705
    [Abstract] [Full Text] [Related]

  • 8. Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.
    Tilakaratne N, Christopoulos G, Zumpe ET, Foord SM, Sexton PM.
    J Pharmacol Exp Ther; 2000 Jul 07; 294(1):61-72. PubMed ID: 10871296
    [Abstract] [Full Text] [Related]

  • 9. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
    Robinson SD, Aitken JF, Bailey RJ, Poyner DR, Hay DL.
    J Pharmacol Exp Ther; 2009 Nov 07; 331(2):513-21. PubMed ID: 19644039
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
    Thota C, Gangula PR, Dong YL, Yallampalli C.
    Biol Reprod; 2003 Oct 07; 69(4):1432-7. PubMed ID: 12801991
    [Abstract] [Full Text] [Related]

  • 12. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
    Oliver KR, Kane SA, Salvatore CA, Mallee JJ, Kinsey AM, Koblan KS, Keyvan-Fouladi N, Heavens RP, Wainwright A, Jacobson M, Dickerson IM, Hill RG.
    Eur J Neurosci; 2001 Aug 07; 14(4):618-28. PubMed ID: 11556887
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3.
    Muff R, Bühlmann N, Fischer JA, Born W.
    Endocrinology; 1999 Jun 07; 140(6):2924-7. PubMed ID: 10342886
    [Abstract] [Full Text] [Related]

  • 15. Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy.
    Nagae T, Mukoyama M, Sugawara A, Mori K, Yahata K, Kasahara M, Suganami T, Makino H, Fujinaga Y, Yoshioka T, Tanaka I, Nakao K.
    Biochem Biophys Res Commun; 2000 Apr 02; 270(1):89-93. PubMed ID: 10733909
    [Abstract] [Full Text] [Related]

  • 16. Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone.
    Lerner UH.
    J Musculoskelet Neuronal Interact; 2006 Apr 02; 6(1):87-95. PubMed ID: 16675892
    [Abstract] [Full Text] [Related]

  • 17. A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptor.
    Gingell JJ, Qi T, Bailey RJ, Hay DL.
    Peptides; 2010 Jul 02; 31(7):1400-4. PubMed ID: 20347903
    [Abstract] [Full Text] [Related]

  • 18. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
    Naot D, Cornish J.
    Bone; 2008 Nov 02; 43(5):813-8. PubMed ID: 18687416
    [Abstract] [Full Text] [Related]

  • 19. The gene expression of adrenomedullin, calcitonin-receptor-like receptor and receptor activity modifying proteins (RAMPs) in CCl4-induced rat liver cirrhosis.
    Hwang IS, Tang F, Leung PP, Li YY, Fan ST, Luk JM.
    Regul Pept; 2006 Jul 15; 135(1-2):69-77. PubMed ID: 16713642
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor.
    Armour SL, Foord S, Kenakin T, Chen WJ.
    J Pharmacol Toxicol Methods; 1999 Dec 15; 42(4):217-24. PubMed ID: 11033437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.